Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related Pain

NCT05382143 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05382143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related Pain
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
February 1, 2022
Completion date
July 1, 2022
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis